Authors:
Gales, AC
Jones, RN
Gordon, KA
Sader, HS
Wilke, WW
Beach, ML
Pfaller, MA
Doern, GV
Citation: Ac. Gales et al., Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY Antimicrobial Surveillance Program (1998), J ANTIMICRO, 45(3), 2000, pp. 295-303
Authors:
Pfaller, MA
Messer, SA
Mills, K
Bolmstrom, A
Citation: Ma. Pfaller et al., In vitro susceptibility testing of filamentous fungi: Comparison of Etest and reference microdilution methods for determining itraconazole MICs, J CLIN MICR, 38(9), 2000, pp. 3359-3361
Authors:
Barry, AL
Pfaller, MA
Brown, SD
Espinel-Ingroff, A
Ghannoum, MA
Knapp, C
Rennie, RP
Rex, JH
Rinaldi, MG
Citation: Al. Barry et al., Quality control limits for broth microdilution susceptibility tests of tenantifungal agents, J CLIN MICR, 38(9), 2000, pp. 3457-3459
Authors:
Pfaller, MA
Mujeeb, I
Hollis, RJ
Jones, RN
Doern, GV
Citation: Ma. Pfaller et al., Evaluation of the discriminatory powers of the dienes test and ribotyping as typing methods for Proteus mirabilis, J CLIN MICR, 38(3), 2000, pp. 1077-1080
Citation: Rn. Jones et Ma. Pfaller, Macrolide and fluoroquinolone (Levofloxacin) resistances among Streptococcus pneumoniae strains: Significant trends from the SENTRY Antimicrobial Surveillance Program (North America, 1997-1999), J CLIN MICR, 38(11), 2000, pp. 4298-4299
Authors:
Pfaller, MA
Messer, SA
Houston, A
Mills, K
Bolmstrom, A
Jones, RN
Citation: Ma. Pfaller et al., Evaluation of the Etest method for determining voriconazole susceptibilities of 312 clinical isolates of Candida species by using three different agar media, J CLIN MICR, 38(10), 2000, pp. 3715-3717
Citation: Ej. Ernst et al., Postantifungal effects of echinocandin, azole, and polyene antifungal agents against Candida albicans and Cryptococcus neoformans, ANTIM AG CH, 44(4), 2000, pp. 1108-1111
Authors:
Pfaller, MA
Jones, RN
Doern, GV
Sader, HS
Messer, SA
Houston, A
Coffman, S
Hollis, RJ
Citation: Ma. Pfaller et al., Bloodstream infections due to Candida species: SENTRY Antimicrobial Surveillance Program in North America and Latin America, 1997-1998, ANTIM AG CH, 44(3), 2000, pp. 747-751
Authors:
Winokur, PL
Brueggemann, A
DeSalvo, DL
Hoffmann, L
Apley, HD
Uhlenhopp, EK
Pfaller, MA
Doern, GV
Citation: Pl. Winokur et al., Animal and human multidrug-resistant, cephalosporin-resistant Salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamase, ANTIM AG CH, 44(10), 2000, pp. 2777-2783
Authors:
Yamazumi, T
Pfaller, MA
Messer, SA
Houston, A
Hollis, RJ
Jones, RN
Citation: T. Yamazumi et al., In vitro activities of ravuconazole (BMS-207147) against 541 clinical isolates of Cryptococcus neoformans, ANTIM AG CH, 44(10), 2000, pp. 2883-2886
Authors:
Gunderson, SM
Hoffman, H
Ernst, EJ
Pfaller, MA
Klepser, ME
Citation: Sm. Gunderson et al., In vitro pharmacodynamic characteristics of nystatin including time-kill and postantifungal effect, ANTIM AG CH, 44(10), 2000, pp. 2887-2890
Citation: Rn. Jones et Ma. Pfaller, Potencies of newer fluoroquinolones against viridans group streptococci isolated in 637 cases of bloodstream infection in the SENTRY antimicrobial surveillance program (1997 to 1999): Beyond Canada!, ANTIM AG CH, 44(10), 2000, pp. 2922-2923
Authors:
Andrews, JI
Diekema, DJ
Hunter, SK
Rhomberg, PR
Pfaller, MA
Jones, RN
Doern, GV
Citation: Ji. Andrews et al., Group B streptococci causing neonatal bloodstream infection: Antimicrobialsusceptibility and serotyping results from SENTRY centers in the Western Hemisphere, AM J OBST G, 183(4), 2000, pp. 859-862
Authors:
Kao, AS
Brandt, ME
Pruitt, WR
Conn, LA
Perkins, BA
Stephens, DS
Baughman, WS
Reingold, AL
Rothrock, GA
Pfaller, MA
Pinner, RW
Hajjeh, RA
Citation: As. Kao et al., The epidemiology of candidemia in two United States cities: Results of a population-based active surveillance, CLIN INF D, 29(5), 1999, pp. 1164-1170
Authors:
Diekema, DJ
Pfaller, MA
Jones, RN
Doern, GV
Winokur, PL
Gales, AC
Sader, HS
Kugler, K
Beach, M
Citation: Dj. Diekema et al., Survey of bloodstream infections due to gram-negative bacilli: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997, CLIN INF D, 29(3), 1999, pp. 595-607
Authors:
Perl, TM
Kruger, WA
Houston, A
Boyken, LD
Pfaller, MA
Herwaldt, LA
Citation: Tm. Perl et al., Investigation of suspected nosocomial clusters of Staphylococcus haemolyticus infections, INFECT CONT, 20(2), 1999, pp. 128-131
Authors:
Rangel-Frausto, MS
Rhomberg, P
Hollis, RJ
Pfaller, MA
Wenzel, RP
Helms, CM
Herwaldt, LA
Citation: Ms. Rangel-frausto et al., Persistence of Legionella pneumophila in a hospital's water system: A 13-year survey, INFECT CONT, 20(12), 1999, pp. 793-797
Authors:
Jones, RN
Erwin, ME
Biedenbach, DJ
Johnson, DM
Pfaller, MA
Citation: Rn. Jones et al., Development of in vitro susceptibility testing methods for gemifloxacin (formerly LB20304a or SB-265805), an investigational fluoronaphthyridone, DIAG MICR I, 35(3), 1999, pp. 227-234
Authors:
Pfaller, MA
Jones, RN
Doern, GV
Salazar, JC
Citation: Ma. Pfaller et al., Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia: Comparison of data from 1997 and 1998 using the Etest method, DIAG MICR I, 35(3), 1999, pp. 235-241
Authors:
Munro, S
Baron, EJ
Robinson, A
Walsh, P
Meier, FA
Hacek, DM
Peterson, LR
Reynolds, JK
Allen, SD
Cockerill, F
Pfaller, MA
Jones, RN
Gilligan, PH
Wait, K
Harrell, LJ
Reller, LB
Hall, G
Mann, LM
Woods, GL
Carroll, KC
Reimer, L
Citation: S. Munro et al., United States geographic bacteria susceptibility patterns, DIAG MICR I, 35(2), 1999, pp. 143-151
Citation: Ma. Pfaller et al., Multicenter evaluation of the antimicrobial activity for six broad-spectrum beta-lactams in Venezuela: Comparison of data from 1997 and 1998 using the Etest method, DIAG MICR I, 35(2), 1999, pp. 153-158